CIK: 1310683 - Address: 2173 Salk Avenue,, Suite 200, Carlsbad, CA 92008
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret1111615-11-44298
P%wins1001000010010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/22/24 09:00
11/21/24
LCTXLineage Cell Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagCulley Brian MCADOP,CEOP240.600004026195D
5/28/24 09:11
5/24/24
LCTXLineage Cell Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagCulley Brian MCADOP,CEOP111.050107155D
4/4/22 16:05
3/31/22
LCTXLineage Cell Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagCulley Brian MCADOP,CEOP.d101.5306798D
3/28/22 19:22
3/25/22
LCTXLineage Cell Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagCulley Brian MCADOP,CEOP71.3805781D
8/15/19 08:39
8/13/19
LCTXLineage Cell Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagCulley Brian MCADOP,CEOP101.010101385D
10/25/17 08:12
10/23/17
ATMSArtemis Therapeutics, Inc.DEChemChemMiscellaneous Chemical ProducCulley Brian MNYOCEOP.d00.00025New25D
3/15/12 16:25
3/14/12
ANXAdventrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsCulley Brian MCADOCEO,DirP120.590402114635D-89-71-35-3-13-17-9-2
3/14/12 16:30
3/13/12
ANXAdventrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsCulley Brian MCADOCEO,DirP80.5817014New14D-89-71-35-3-13-17-9-2
5/27/10 16:10
5/27/10
ANXAdventrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsCulley Brian MCAOCEOP91.8925New5D-83-43-17-75-72-19-18-21615-11-4429

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact